Literature DB >> 19840507

Nontuberculous mycobacterial lung disease in southern Taiwan.

Chin-Chou Wang1, Meng-Chih Lin, Jien-Wei Liu, Yi-Hsi Wang.   

Abstract

BACKGROUND: The aim of this study was to assess the prevalence of the major nontuberculous mycobacterium (NTM) species and the outcome of their treatment in southern Taiwan (a high-prevalence area for mycobacterium tuberculosis [MTB]).
METHODS: The study was a retrospective review of patients with NTM pulmonary disease at the Kaohsiung Chang Gung Memorial Hospital from 2004 to 2005. The variables recorded and analyzed included demographics, particularly age and gender; primary clinical presentations; chest radiographic findings; risk factors; medication and outcome of treatment.
RESULTS: The study included 67 patients with NTM pulmonary disease. The average age was 66.6+/-14.5 years and they were predominantly male (70.1%). Of these patients, 88.1% had pre-existing lung disease, with chronic obstructive pulmonary disease (61.2%) and TB (58.2%) as the main underlying lung diseases. Rapid-growth species (M. abscessus, 44.8% and M. fortuitum, 23.9%)were the most commonly isolated species. Of the forty patients that were treated and followed up for at least one year, 31 had a favorable outcome (mean duration of therapy, 8.46+/-2.96 months).
CONCLUSIONS: The predominant species in southern Taiwan differ from those in other countries as well as in northern Taiwan, with rapid-growth species predominating in southern Taiwan.

Entities:  

Mesh:

Year:  2009        PMID: 19840507

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  5 in total

Review 1.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

Authors:  D Rebecca Prevots; Theodore K Marras
Journal:  Clin Chest Med       Date:  2014-11-06       Impact factor: 2.878

2.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

3.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

4.  Radiological findings in nontuberculous mycobacterial pulmonary diseases: A comparison between the Mycobacterium avium complex and the Mycobacterium abscessus complex.

Authors:  Hiroaki Nagano; Takeshi Kinjo; Jiro Fujita; Tomoo Kishaba
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

5.  Causative species of nontuberculous mycobacterial lung disease and comparative investigation on clinical features of Mycobacterium abscessus complex disease: A retrospective analysis for two major hospitals in a subtropical region of Japan.

Authors:  Hiroaki Nagano; Takeshi Kinjo; Yuichiro Nei; Shin Yamashiro; Jiro Fujita; Tomoo Kishaba
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.